New insider activity at Labcorp Holdings ( (LH) ) has taken place on March 3, 2026.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Labcorp Holdings has reported an insider stock transaction involving EVP, Corporate Affairs Sandra D van der Vaart, who sold 547 shares of the company’s stock. The total value of this sale amounts to $155,845, highlighting a notable move by a key executive within the organization.
Recent Updates on LH stock
Labcorp Holdings’ shares reacted to its Q4 and full‑year update, where revenue and EPS grew solidly, margins expanded and free cash flow increased, though quarterly sales were slightly below consensus. Analysts’ latest stance appears driven by sustained strength in Diagnostics and Central Labs, robust backlog and 2026 growth guidance, partly offset by ongoing pressure in Early Development, higher capex needs and policy reimbursement uncertainties that temper the otherwise upbeat outlook.
Spark’s Take on LH Stock
According to Spark, TipRanks’ AI Analyst, LH is a Outperform.
The score is driven by improving operational outlook and supportive technical momentum (price above key moving averages with positive MACD), partly offset by only solid—not exceptional—financial consistency (margin and FCF variability) and a relatively high P/E with a modest dividend yield.
To see Spark’s full report on LH stock, click here.
More about Labcorp Holdings
YTD Price Performance: 14.47%
Average Trading Volume: 725,107
Technical Sentiment Signal: Buy
Current Market Cap: $23.61B